Thursday, December 6 |
| 12:00 noon – 7:00 p.m. |
Attendee Registration |
| 2:00 p.m. – 8:00 p.m. |
Training Program Directors Workshop/Business Meeting |
| Friday, December 7 |
| 7:00 a.m. – 7:00 p.m. |
Attendee Registration |
| 7:00 a.m. – 11:00 a.m. |
Friday Satellite Symposia (nonprofit organizations) |
| 7:00 a.m. – 12:00 noon |
Trainee Day (open to trainees only) |
| 12:30 p.m. – 10:00 p.m. |
Friday Satellite Symposia (nonprofit and for-profit organizations) |
| 4:30 p.m. – 6:00 p.m. |
Trainee Welcome Reception and Meeting Overview (open to trainees only) |
| Saturday, December 8 |
| 7:00 a.m. – 6:00 p.m. |
Attendee Registration |
7:30 a.m. – 9:00 a.m. |
Education/Scientific Program
- Chronic Lymphocytic Leukemia
- Chronic Myeloid Leukemia
- Gene Therapy: Progress and Challenges
- Hematopoietic Stem Cell Transplant
- Pitfalls of Clinical Trials and Their Interpretation
- Rational Therapeutic Targets in Large B-Cell and Mantle Cell Lymphomas
- RBCs and Hemoglobinopathies
- Thrombosis and Bleeding Complications in Malignant Hematologic Disorders
- Transfusion Medicine (ASH/AABB joint session)
- SC: Hemoglobin/Red Cell - Folate Biology and the Broad Implications of Folate Status: New Developments
- SC: Lymphocyte Biology - Systems Biology
- SC: Lymphoid Neoplasia - NF-kB Signaling in Lymphoid Neoplasia: Deregulation and Targeting
- SC: Myeloid Biology - Translational Research in Myeloid Disorders
- SC: Platelets - Platelet Granule Biogenesis and Secretion
|
| 9:00 a.m. – 9:30 a.m. |
Coffee Break (poster hall) |
| 9:00 a.m. – 7:30 p.m. |
Poster Session I – Viewing |
| 9:30 a.m. – 11:00 a.m. |
Education/Scientific Program
- Bone Marrow Failure Syndromes
- Challenging Cases in Acute Leukemia
- Hodgkin Lymphoma
- Myelodysplastic Syndromes
- Novel Immunotherapeutic Approaches for Lymphoma
- Sickle Cell Anemia
- Stem Cells
- Thrombophilia
- SC: Hemostasis - Hemostasis and Inflammation
- SC: Iron and Heme - From Heme to Heme: Physiology of Iron Recycling and Its Disorders
- SC: Pediatric Hematology - Personalized Medicine in Hematologic Disorders
- SC: Thrombosis and Vascular Biology - Pathophysiology of Microangiopathies
- SC: Transplantation Biology - Natural Killer Cells: Biology and Therapy
|
| 9:30 a.m. – 11:00 a.m. |
Special Session: Practical and Ethical Issues Arising During the Conduct of Pharmaceutical-Industry-Sponsored Research (offered only once) |
| 11:00 a.m. – 12:30 p.m. |
Open Time for Lunch |
| 11:00 a.m. – 7:00 p.m. |
Exhibits Open |
| 11:15 a.m. – 12:15 p.m. |
Meet-the-Expert Sessions (ticketed sessions) |
| 11:15 a.m. – 12:15 p.m. |
Trainee Simultaneous Didactic Sessions (open to trainees only) |
| 12:30 p.m. – 1:30 p.m. |
Ham-Wasserman Lecture |
| 1:30 p.m. – 2:00 p.m. |
Coffee Break (exhibit and poster halls) |
| 2:00 p.m. – 3:30 p.m. |
Education/Scientific Program
- Chronic Myeloid Leukemia
- Follicular Lymphoma
- Gene Therapy: Progress and Challenges
- Multiple Myeloma
- Myeloproliferative Disorders
- Platelet Disorders
- SC: Clinical Laboratory Hematology - Pathophysiology of Immune-Mediated Thrombotic Disorders
- SC: Hematopoietic Cytokine and Factors - Myelodysplastic Syndromes
- SC: Myeloid Neoplasia - Targeting Transcription Factors
- SC: Stem Cells - Leukemia Stem Cells
- SC: Transfusion Medicine - The Scientific Basis of Innate Immunity in Transfusion and Bone Marrow Transplantation
|
| 2:00 p.m. – 3:30 p.m. |
Special Educational Symposium: Thrombosis in the Elderly: A Public Health and Scientific Problem of Unrecognized Dimensions (offered only once) |
| 2:00 p.m. - 3:30 p.m. |
Hematology Grants I: Career Development Grants (offered only once) |
| 3:30 p.m. – 4:00 p.m. |
Coffee Break (exhibit and poster halls) |
| 4:00 p.m. – 5:30 p.m. |
Education/Scientific Program
- Acute Myeloid Leukemia
- Hodgkin Lymphoma
- Hematopoietic Stem Cell Transplant
- Pediatric Hematologic Malignancies
- Pitfalls of Clinical Trials and Their Interpretation
- Stem Cells
- Transfusion Medicine (ASH/AABB joint session)
- SC: Hemoglobin/Red Cell - Folate Biology and The Broad Implications of Folate Status: New Developments
- SC: Lymphocyte Biology - Systems Biology
- SC: Lymphoid Neoplasia - NF-kB Signaling in Lymphoid Neoplasia: Deregulation and Targeting
- SC: Myeloid Biology - Translational Research in Myeloid Disorders
- SC: Platelets - Platelet Granule Biogenesis and Secretion
|
| 4:00 p.m. – 5:30 p.m. |
Special Session: Venous Thromboembolism: A Common Blood Clotting Disorder from Patient, Public Health, and Scientific Perspectives (offered only once) |
| 4:00 p.m. – 5:30 p.m. |
Research Development Forum (offered only once) |
| 5:30 p.m. – 7:30 p.m. |
Poster Session I – Presentations |
| 5:30 p.m. – 7:30 p.m. |
Welcome Reception (exhibit and poster halls)
*Exhibit hall closes at 7:00 p.m. |
| 6:00 p.m. – 7:00 p.m. |
How to Prepare Images for Publication in Blood: Issues in Image Manipulation |
| 6:00 p.m. – 7:30 p.m. |
Practice Forum |
| 6:30 p.m. – 9:00 p.m. |
Promoting Minorities in Hematology Presentations and Reception |
| Sunday, December 9 |
| 7:00 a.m. – 8:00 a.m. |
ASH Grassroots Network Breakfast |
| 7:00 a.m. – 9:00 a.m. |
Hematology Course Directors Meeting |
| 7:00 a.m. – 5:00 p.m. |
Attendee Registration |
| 7:30 a.m. – 9:00 a.m. |
Education/Scientific Program
- Challenging Cases in Acute Leukemia
- Chronic Lymphocytic Leukemia
- Follicular Lymphoma
- Myelodysplastic Syndromes
- Platelet Disorders
- Sickle Cell Anemia
- Thrombophilia
- Thrombosis and Bleeding Complications in Malignant Hematologic Disorders
- SC: Clinical Laboratory Hematology - Pathophysiology of Immune-Mediated Thrombotic Disorders
- SC: Myeloid Neoplasia: Targeting Transcription Factors
- SC: Pediatric Hematology - Personalized Medicine in Hematologic Disorders
- SC: Transfusion Medicine - The Scientific Basis of Innate Immunity in Transfusion and Bone Marrow Transplantation
- SC: Transplantation Biology - Natural Killer Cells: Biology and Therapy
|
| 7:30 a.m. - 9:00 a.m. |
Hematology Grants II: How to Get Your First and the All-Important Second NIH R01 Grant (offered only once) |
| 9:00 a.m. – 9:30 a.m. |
Coffee Break (poster hall) |
| 9:00 a.m. – 8:00 p.m. |
Poster Session II – Viewing |
| 9:30 a.m. – 11:00 a.m. |
ASH/ASCO Joint Symposium: Infection, Inflammation, and Cancer (offered only once) |
9:30 a.m. – 11:00 a.m. |
Education/Scientific Program
- Acute Myeloid Leukemia
- Bone Marrow Failure Syndromes
- Multiple Myeloma
- Myeloproliferative Disorders
- Novel Immunotherapeutic Approaches for Lymphoma
- Pediatric Hematologic Malignancies
- Rational Therapeutic Targets in Large B-Cell and Mantle Cell Lymphomas
- RBCs and Hemoglobinopathies
- SC: Hematopoietic Cytokine and Factors - Myelodysplastic Syndromes
- SC: Heostasis - Hemostasis and Inflammation
- SC: Iron and Heme - From Heme to Heme: Physiology of Iron Recycling and Its Disorders
- SC: Stem Cells - Leukemia Stem Cells
- SC: Thrombosis and Vascular Biology - Pathophysiology of Microangiopathies
|
| 11:00 a.m. – 12:30 p.m. |
Open Time for Lunch |
| 11:00 a.m. – 4:30 p.m. |
Exhibits Open |
| 11:15 a.m. – 12:15 p.m. |
Meet-the-Expert Sessions (ticketed sessions) |
| 11:15 a.m. – 12:15 p.m. |
Trainee Simultaneous Didactic Sessions (open to trainees only) |
| 12:30 p.m. – 1:30 p.m. |
ASH/EHA Policy Forum |
| 1:30 p.m. – 4:00 p.m. |
Plenary Scientific Session
Announcement of Awards
- Mentor Awards
- Outstanding Service Award
- Public Service Award
|
| 4:00 p.m. – 4:30 p.m. |
Coffee Break (exhibit and poster halls) |
| 4:30 p.m. – 6:00 p.m. |
Simultaneous Sessions
- Acute Lymphocytic Leukemias: Ph+ Disease
- AML Susceptibility and Progression Factors
- Autologous Transplantation for Lymphoma
- Chronic Myeloid Leukemia: Early Chronic Phase CML Therapy
- Chronic Myeloid Leukemia: Mechanisms of Disease and Genomic Instability
- Clinical Care: Acute and Chronic GVHD Post Allogeneic Stem Cell Transplantation
- Clinical Results: Alternative Donor Transplantation: HLA Match and Other Factors Influencing Outcome
- Diffuse Large B Cell Lymphoma: Prognosis
- Disordered Gene Expression in Leukemia
- Experimental Transplantation: Basic Biology and Immune Function
- Experimental Transplantation: GVHD and GVL
- First-Line Phase III Trials in Multiple Myeloma
- Health Services and Outcomes Research: Non-Malignant Hematology
- Hematopoiesis: Cytokines and Signal Transduction
- Hematopoietic Stem and Progenitor Biology: Stem Cell
- Megakaryocyte and Platelet Development
- Molecular Signatures in AML
- Multiple Myeloma: Mediators of Apoptosis
- Myelodysplastic Syndromes: Molecular Biology/Pathogenesis
- Novel Therapeutic Agents for Non-Hodgkin Lymphoma
- Pathophysiology of Thrombosis: Risk Factors
- Platelet Activation and Biochemistry
- Red Cell Structure/Function, Metabolism, and Survival: Red Cells
- Sickle Cell Disease: Cell Adhesion, Density, and Vaso-Occlusion
|
| 4:30 p.m. – 6:00 p.m. |
Education Spotlight Sessions
(ticketed sessions)
- Post-Remission Therapy in Acute Myeloid Leukemia
- How the New Response Criteria for NHL Will Alter Clinical Care and Research Design
- Amyloidosis
|
| 6:00 p.m. – 8:00 p.m. |
Reception (poster hall) |
| 6:00 p.m. – 8:00 p.m. |
Poster Session II – Presentations |
| Monday, December 10 |
| 7:00 a.m. – 5:00 p.m. |
Attendee Registration |
| 7:30 a.m. – 9:00 a.m. |
Simultaneous Sessions
- Acute Lymphocytic Leukemia: Biology and Pathophysiology I
- Acute Myeloid Leukemias: Therapy, excluding Transplantation-Immunotherapeutic Approaches
- Clinical Care: Infection, GVH and Immune Reconstitution Post Stem Cell Transplant
- Clinical Results: Alternative Donor Transplantation: Matched Unrelated Donors/Comparative Studies
- Experimental Transplantation: Basic Biology and Engraftment
- Follicular Lymphoma: Transformation
- Front-Line Therapy in Newly Diagnosed Multiple Myeloma
- Gene Therapy: Pre-Clinical Animal Models
- Hematopoietic Stem and Progenitor Biology: Signaling in Hematopoietic Stem Cells
- Identification of Novel Mutations and Therapeutic Targets in AML
- Lymphoma: Chemotherapy, excluding Pre-Clinical Models: Hodgkin and PET
- Molecular Effectors of Stem Cell Migration
- Molecular Pharmacology: Molecular Determinants of Responsiveness
- Molecular Signatures in ALL and AML
- Mononuclear Phagocyte Differentiation and Function
- Multiple Myeloma: MGUS Progression; Signal Transduction
- Myelodysplastic Syndromes: Clinical Advances: Therapy (including Transplantation) and Cytogenetics
- Myeloma: Pathophysiology and Pre-Clinical Studies excluding Therapy: Novel Targets
- Myeloproliferative Syndromes: Biology
- Regulation of Coagulation
- Thalassemia: Globin Gene Regulation/Erythropoiesis
- TTP, HIT, and Drug-Induced Thrombocytopenia
- Tumor Immunotherapy: Cancer Vaccines, Tumor Antigens, and Adoptive Immunotherapy
- Vascular Wall Biology and Platelet Adhesion
|
| 7:30 a.m. – 9:00 a.m. |
Education Spotlight Sessions (ticketed sessions)
- Challenges in Hematopathology
- Consultative Hematology
|
9:30 a.m. – 10:30 a.m. |
E. Donnall Thomas Lecture: The Road to and Future of Cord Blood Transplantation
|
| 10:30 a.m. – 11:00 a.m. |
Coffee Break (exhibit and poster halls) |
| 10:30 a.m. – 3:30 p.m. |
Exhibits Open |
| 10:30 a.m. – 7:00 p.m. |
Poster Session III – Viewing |
| 11:00 a.m. – 12:30 p.m. |
Simultaneous Sessions
- Acute Myeloid Leukemias: Therapy, excluding Transplantation-Results of Clinical Trials
- Antithrombotic Therapy: Management of Anticoagulation
- Antithrombotic Therapy: New Anticoagulants
- Cellular Immunology, Differentiation and Animal Models
- Chronic Myeloid Leukemia: Response, Molecular Response and BCR-ABL Mutations
- Clinical Results: Allogeneic Matched Related Donor Transplantation
- Clinical Results: Alternative Donor Transplantation: Umbilical Cord Blood/Comparative Studies, Selection Criteria, and New Approaches
- CLL: Signaling Pathways
- Disordered Gene Expression in Hematologic Malignancy including Disordered Epigenetic Regulation
- Experimental Transplantation: Suppression of GVHD
- Follicular Lymphoma: Immunosurveillance
- Gene Mutations in AML
- Health Services and Outcomes Research: Lymphoma and Anemia
- Hematopoiesis: Regulation of Gene Transcription
- Hodgkin Lymphoma: Biology, excluding Therapy
- Lymphoma: Chemotherapy, excluding Pre-Clinical Models: Follicular and Mantle Cell Lymphoma
- Multiple Myeloma: Genomic Approaches to Pathogenesis
- Myelodysplastic Syndromes: Biology and Animal Models
- Novel Functions of Fibrinolytic and Coagulation Proteins
- Novel Therapies in Relapsed Multiple Myeloma
- Platelet Activation and Biochemistry
- Red Cell Regulation and Disorders of Production
- Sickle Cell: CNS Disease, Risk Factors, and Outcomes
- Stem Cells and Their Derivatives
|
| 11:00 a.m. – 12:30 p.m. |
Education Spotlight Sessions (ticketed sessions)
- Thrombosis Prevention and Management in High-Risk Clinical Situations
- Hemolytic Anemia: PNH and Hemolytic Anemia
|
| 12:30 p.m. – 1:30 p.m. |
ASH Career Development Lunch Sessions (open to trainees only) |
| 12:30 p.m. – 1:30 p.m. |
Open Time for Lunch |
| 1:30 p.m. – 3:00 p.m. |
Simultaneous Sessions
- Acute Myeloid Leukemias: Therapy, excluding Transplantation-Novel therapies
- Autologous Transplantation for Myeloma: Induction, Mobilization, and Biologic Correlates
- Basic Science and Clinical Practice in Blood Transfusion
- Chromosomal Rearrangements
- Chronic Myeloid Leukemia: New Molecular Targets
- Chronic Myeloid Leukemia: Therapy of the CML Advanced Phases
- Clinical Care: Transplantation Regimen Toxicities and Engraftment: Donor Issues and Transplant Centers
- Clinical Results: Allogeneic Matched Related Donor Transplantation
- CLL: Genetics and Epigenetics
- Disorders of Coagulation or Fibrinolysis
- Gene Therapy: Results from Clinical Trials
- Hematopoietic Stem and Progenitor Biology
- Immunodeficiency, including HIV and Other Infections
- Lymphoma: Chemotherapy, excluding Pre-Clinical Models: Aggressive lymphoma
- Lymphoma: Pre-Clinical: Chemotherapy and Biologic Agents: Novel Therapies including BCL-6 Pathways and Monoclonal Antibodies
- Maintenance, Consolidation and Bone Disease in Multiple Myeloma
- Molecular Pharmacology: Novel Therapies I
- MRD and Novel Diagnostic Approaches in AML
- Myeloma: Pathophysiology and Pre-Clinical Studies excluding Therapy: New Models
- Myeloproliferative Syndromes: Therapy
- Non-Hodgkin Lymphoma: Lymphomagenesis
- Novel Therapy for ITP
- Thalassemia: Pre-Clinical and Clinical Advances
- Tumor Immunotherapy: Cancer Vaccines and Adoptive Immunotherapy in the Context of Transplantation
|
| 3:00 p.m. – 3:30 p.m. |
Coffee Break (exhibit and poster halls) |
| 3:30 p.m. – 5:00 p.m. |
Simultaneous Sessions
- Acute Lymphocytic Leukemias: Pediatric and Adult Clinical Trials
- Acute Myeloid Leukemias: Therapy, excluding Transplantation-Acute Promyelocytic leukemia
- AML Pathogenesis and Prognostic Markers
- Autologous Transplantation: Clinical Results
- Biology of the Stem Cell Milieu
- Clinical Care: Transplantation Regimen Toxicities and Engraftment: Regimen Related Toxicities
- Clinical Care: Transplantation Regimen Toxicities and Engraftment: Regimens and Clinical Issues
- CLL: Progress in Frontline Therapies
- Health Services and Outcomes Research: Hematologic Malignancies
- Hematopoiesis: Apoptosis and Cell Cycle Regulation
- Immunotherapy for Lymphoma, including Radio-Immunotherapy
- Molecular Pharmacology: Novel Therapies II
- Multiple Myeloma: Biochemical & Genetic Prognosticators
- Myeloid Differentiation and Neutropenia
- Myeloma: Pathophysiology and Pre-Clinical Studies excluding Therapy: Signaling Pathways
- Myeloproliferative Syndromes: Clinical and Molecular Profiling
- Myeloproliferative Syndromes: Clinical and Stem Cell Transplantation
- Non-Hodgkin Lymphoma: Therapeutic Targets
- Oncogenes and Tumor Suppressors
- Pathophysiology of Thrombosis: Predictors for Thrombosis
- Red Cell Structure/Function, Metabolism, and Survival: Iron
- von Willebrand Disease
|
| 5:00 p.m. – 7:00 p.m. |
Poster Session III – Presentations |
| 5:00 p.m. – 7:00 p.m. |
Reception (poster hall) |
| 7:00 p.m. – 9:30 p.m. |
ASH Bash: Rubbing Fins with Fishes and Friends, a special networking event at the Georgia Aquarium (ticketed event) |
| Tuesday, December 11 |
| 7:00 a.m. – 1:30 p.m. |
Attendee Registration |
7:30 a.m. – 9:00 a.m. |
Simultaneous Sessions
- Aberrant Transcriptional and Translational Control in AML
- Acute Lymphocytic Leukemia: Biology and Pathophysiology II
- Autologous Transplantation for Plasma Cell Disorders: Transplant Regimens
- Chronic Myeloid Leukemia: Therapy of Resistant and Intolerant CML Cases
- CLL: B-Cell Receptor and Signaling
- CLL: Clinical Biology
- CLL: Salvage Therapies and Treatment Precautions
- Cytogenetics and Associated Genetic Factors in Acute Leukemia
- Factor VIII and Factor XI
- Graft Engineering and Stem Cell Mobilization
- Hematopoiesis: Malignant Stem and Progenitor Cells
- Hemophilia Inhibitors (Alloantibody)
- Immuno-Chemotherapy for Diffuse Large B-Cell and Follicular Lymphoma
- Lymphocyte and NK Cell Signaling
- Lymphoma: Pre-Clinical: Chemotherapy and Biologic Agents: Novel Agents including Small Molecule Inhibitors
- Molecular Pharmacology: Drug Resistance
- Multiple Myeloma: Regulators of Osteoblast and Osteoclast Activity
- Myelodysplastic Syndromes: Advances in Therapeutic Options
- Oncogenes and Tumor Suppressors
- Recurrence, Second Cancers and Late Complications after Transplantation
- Red Cell Regulation and Disorders of Production
- Sickle Cell Disease: Hypoxia, Hemolysis, and Nitric Oxide Metabolism
|
| 9:00 a.m. – 9:30 a.m. |
Coffee Break |
| 9:30 a.m. – 12:00 noon |
Presidential Symposium
- Announcement of the Dameshek Prize and Stratton Medal
- Symposium
- Business Meeting
|
| 12:00 noon – 1:00 p.m. |
Best of ASH |
| 1:30 p.m. – 5:30 p.m. |
Special Symposium on the Basic Science of Hemostasis and Thrombosis |
